RAG-17 Archives - Ractigen Therapeutics

Company News RAG-17

NANTONG and SUZHOU, China, Sep.10, 2024 — Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to…

ractigenSeptember 10, 2024

Company News RAG-17

JIANGSU, CHINA (May 15, 2024) – Ractigen Therapeutics, a clinical-stage pharmaceutical company committed to developing…

ractigenMay 15, 2024

Company News RAG-17

Study aims to evaluate the safety and feasibility of RAG-17 in human patients and clinically validate Ractigen’s…

EnvisionJune 10, 2023

Company News RAG-17

Jiangsu, China — Ractigen Therapeutics announced today that the U.S. Food and Drug Administration (FDA)…

EnvisionMarch 3, 2023

RAG-17